January 5, 2022

January 5, 2022

Patient Advice – Paying it Forward – Deborah Dana

Thank you to all our Patient Advocates who have participated. This program is being made possible by sponsorship from AbbVie and Genentech.

January 5, 2022

The Genetics of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) in African Americans and Other Minorities

Sadly, there has been very little research on minority populations with chronic lymphocytic leukemia/small lymphocytic lymphoma. Dr. Slager in partnership with Dr. Esteban Braggio, Mayo Clinic, is hoping to start to remedy that knowledge gap with a trial specifically for minorities with CLL.

January 5, 2022

Real-World Testing Patterns for Risk Assessment and Implications on the Adoption of Novel Therapeutics in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: IGHV Mutation Status, FISH Cytogenetic, and Immunophenotyping

As new and better treatments are developed to treat Chronic Lymphocytic Leukemia, and Small Lymphocytic Lymphoma (CLL/SLL), testing for subtypes of the disease is becoming more important for prognosis and selection of the best treatment options.

January 5, 2022

Patient Advice – Paying it Forward – Deborah Dana

The Genetics of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) in African Americans and Other Minorities

Real-World Testing Patterns for Risk Assessment and Implications on the Adoption of Novel Therapeutics in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: IGHV Mutation Status, FISH Cytogenetic, and Immunophenotyping

CLL SOCIETY FAST FIND

QUICK LINKS

ABOUT US

CONTACT